About Bioage
Bioage is a company based in Niagara Falls (United States) founded in 2001. Bioage has raised $23 million across 1 funding round from investors including Khosla Ventures, Pear VC and Felicis Ventures. Bioage operates in a competitive market with competitors including Microphyt, Olmix, Euglena, Cyanotech and Provectus Algae, among others.
- Headquarter Niagara Falls, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23 M (USD)
in 1 rounds
-
Latest Funding Round
$23 M (USD), Series B
Jan 24, 2018
-
Investors
Khosla Ventures
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bioage
Bioage has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series B round of $23 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioage
Bioage has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Pear VC and Felicis Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in technology startups are made by Felicis Ventures.
|
Locked | Locked | Locked | |
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked |
Investor details for Bioage
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioage
Investment portfolio details for Bioage
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioage
Detailed financials for Bioage
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioage Comparisons
Peer comparison for Bioage
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioage
Bioage operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Microphyt, Olmix, Euglena, Cyanotech and Provectus Algae, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microalgae cultivation technology is developed and supplied.
|
|
| Locked | Locked | Locked |
Developing and marketing algal extracts for use in plant, animal and human health products
|
|
| Locked | Locked | Locked |
Developing and marketing microalgae for use in functional foods
|
|
| Locked | Locked | Locked |
Natural ingredient-based health supplements are provided by Cyanotech.
|
|
| Locked | Locked | Locked |
Algae-based bio-products are produced using AI-driven technology.
|
Detailed competitors of Bioage
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioage
Complete news archive for Bioage
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioage
Bioage was founded in 2001 and raised its 1st funding round 17 years after it was founded.
Bioage is headquartered in Niagara Falls, United States. It is registered at Niagara Falls, New York, United States.
Bioage is a funded company, having raised a total of $23M across 1 funding round to date.
Manufacturer of algal extracts nutritional products. The company offers dietary supplements for pets and humans that help in the prevention of chronic conditions, and support fitness and performance.
Bioage's top competitors include Microphyt, Provectus Algae and Olmix.
Bioage has 7 investors. Key investors include Khosla Ventures, Pear VC, Felicis Ventures, Andreessen Horowitz, and Caffeinated Capital.